Zejula, Revatio Advisory Committee Meetings Cancelled; Palovarotene Panel Postponed

Cancelled meeting
FDA cancels two advisory committee meetings, including 22 November consideration of Zejula sNDA, and postpones another • Source: Shutterstock

More from US FDA Performance Tracker

More from Regulatory Trackers